Get notified when TSHA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TSHA Taysha Gene Therapies, Inc. 8-K

Taysha Gene Therapies reports 2025 full-year financial results

Filed March 19, 2026 · Period ending March 19, 2026 · ~1 min read

Key Changes

  • medium

    Company announced 2025 full-year financial results and business highlights via press release on March 19, 2026. Actual financial figures and operational updates are contained in the attached exhibit.

    Item 2.02 verify on EDGAR →
  • medium

    This is a standard earnings announcement filing. The 8-K body does not contain specific financial metrics or business updates, which are furnished separately in the press release exhibit.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade TSHA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify